Research and Markets: In Argentina's Pharmaceuticals and Healthcare Market France's Sanofi-Aventis Has Invested In a Hepatitis B Antigens Facility, But Multinationals Remain Generally Cautious on the Market.DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c60224) has announced the addition of Argentina Pharmaceuticals & Healthcare Report Q4 2006 to their offering. The Argentina Pharmaceuticals & Healthcare Report provides independent forecasts and competitive intelligence on Argentina's pharmaceuticals & healthcare industry. The Argentine pharmaceutical market was valued at US$2.3bn in 2005 and continues to expand steadily. Sales are expected to reach US$3.25bn in 2010. While the market has recovered from the 2002 economic crash in unit terms, sales value expressed in US dollar terms has still not reached its former level. Such a development is unlikely in the medium to long term, as the currency is not expected to return to its value prior to the termination of so-called convertibility in the wake of the crisis. Although the over-the-counter (OTC OTC See: Over-the-counter. OTC See over-the-counter market (OTC). ) market is likely to remain minor at less than 10% of sales, this obscures the fact that many prescription drugs are available under the counter in Argentina. Accordingly, although regulatory conditions for the non-prescription sector are better than in many other Latin American markets, medicines requiring presentation of a doctor script, and generic products in particular, are likely to record significantly stronger demand growth over the forecast period. This is attributable to the pervasive influence of the public sector in pharmaceutical reimbursement, with welfare schemes expressly purchasing copy medicines, mainly of local origin. This quarter, BMI BMI body mass index. BMI abbr. body mass index Body mass index (BMI) A measurement that has replaced weight as the preferred determinant of obesity. has not changed its view that the market remains difficult for R&D-based multinationals. These companies will capture a lesser share of the forecasted value growth than indigenous firms, which will continue to benefit from discriminatory pricing and lax enforcement of patents. A pharmaceutical price freeze Noun 1. price freeze - a freeze of prices at a given level freeze - fixing (of prices or wages etc) at a particular level; "a freeze on hiring" affecting some 20% of all products registered in Argentina was implemented in late 2005 and has now been extended until at least the end of 2006 as the government continues to battle resurgent re·sur·gent adj. 1. Experiencing or tending to bring about renewal or revival. 2. Sweeping or surging back again. Adj. 1. inflation. The government has since refused to discuss the 'voluntary' accord with manufacturers and has extended it to the distribution sector. Faced with such a poor environment for hi-tech medicines, multinationals including US major Bristol-Myers Squibb Bristol-Myers Squibb (NYSE: BMY), colloquially referred to as BMS, is a pharmaceutical corporation, formed by a 1989 merger between pharmaceutical companies Bristol-Myers Company, founded in 1887 by William McLaren Bristol and John Ripley Myers in Clinton, NY (both were and Germany's Altana have exited the local manufacturing sector in recent months. More positively, France's Sanofi-Aventis has invested in a hepatitis B antigens hepatitis B antigen Hepatitis B surface antigen, see there facility, but multinationals remain generally cautious on the market. The sizeable indigenous sector, meanwhile, continues to consolidate around a few leading players, which are increasingly turning to international markets in order to maintain revenue flows. Business Environment Rankings for Argentina reflect this state of affairs, placing Argentina last out of the eight major Latin American markets surveyed. Argentina's position is below that of Peru, reflecting the impact of US free trade agreements in the Andean region Andean region may refer to:
Content Outline: Chapter - Executive Summary Argentina Pharmaceuticals & Healthcare Industry SWOT Argentina Political SWOT Argentina Economic SWOT Argentina Business Environment SWOT Chapter - Argentina: Business Environment Ranking Business Environment Ranking Economics - Long-Term Risk Politics - Long-Term Risk Regulatory Barriers Domestic Sector Threat Market Growth Potential Market Size Ranking Chapter - Argentina: Market Summary Table: Market Share of Leading Drug Distributors Chapter - Industry Trends & Developments Regulatory Regime Intellectual Property Environment Table: Joint Declaration by Latin American Health American Health Inc. is a company that manufactures health supplements. It is located in Holbrook, New York. One of its products is labeled the "Chewable Original Papaya Enzyme" with the attached registered trademark, "The 'After Meal Supplement'". Ministers, May 2006 Pricing & Reimbursement Issues Timeline: Argentinas Drug Price Freeze (2005-06) Other Regulatory Issues Table: MNC MNC See: Multinational corporation investment In Laboratory Testing In Argentina Chapter - Industry Developments Healthcare Sector Pharmaceutical Sector Market Performance Retail Pharmacy Sector Multinational Sector Developments Domestic Manufacturing Sector Vaccines Sector Chapter - Industry Forecast Scenario Overall Market Forecast Table: Drug Market Indicators Key Growth Factors - Industry Key Growth Factors - Macroeconomic mac·ro·ec·o·nom·ics n. (used with a sing. verb) The study of the overall aspects and workings of a national economy, such as income, output, and the interrelationship among diverse economic sectors. Table: Economic Activity - Historical Data And Forecasts Prescription Market Forecast Table: Prescription Drug Market Indicators Non-Prescription Market Forecast Advertising Competitive Landscape - OTC Pharmaceuticals Table: OTC Market Noun 1. OTC market - a stock exchange where securities transactions are made via telephone and computer rather than on the floor of an exchange over-the-counter market Indicators Generics Market Forecast Table: Generics and Branded Market Indicators Export/Import Forecasts Table: Import and Export Trade Indicators Other Healthcare Data Forecasts Table: Socio-Demographic Indicators Key Risks To BMI's Forecast Scenario Chapter - Competitive Landscape Chapter - Company Monitor Chapter - Latin America: Regional Market Overview BMI Forecast Modelling How We Generate Our Industry Forecasts Technical Process Pharmaceutical Industry Sources Chapter - Appendix: Regional Demographic Data . Wages (ave per annum Per annum Yearly. ), US$ Population Household Spending Per Capita [Latin, By the heads or polls.] A term used in the Descent and Distribution of the estate of one who dies without a will. It means to share and share alike according to the number of individuals. , US$ Private Consumption Per Capita, US$ PPP (Point-to-Point Protocol) The most popular method for transporting IP packets over a serial link between the user and the ISP. Developed in 1994 by the IETF and superseding the SLIP protocol, PPP establishes the session between the user's computer and the ISP using Market Size, GDP GDP (guanosine diphosphate): see guanine. , US$bn Chapter - Country Snapshot: Argentina Demographic Data . Section 1: Population Table: Demographic Indicators (2005) Table: Rural/Urban Breakdown Section 2: Education & Healthcare Table: Education Table: Healthcare: Vital Statistics Table: Healthcare: Expenditure Section 3: Labour Market And Spending Power The power of legislatures to tax and spend. Spending power is conferred to state and federal legislatures through their constitution. Judicial Review of legislative spending varies from state to state, but the law of federal spending informs courts in all states. Table: Employment Indicators Table: Consumption and Stratification Table: Wages per year Companies Mentioned: - Boehringer Ingelheim - GlaxoSmithKline (GSK GSK GlaxoSmithKline plc (pharmaceutical company) GSK Glycogen Synthase Kinase GSK Gruppentraining Sozialer Kompetenzen (Germany) GSK Greenland Shark (FAO fish species code) ) - Laboratorios Bago - Laboratorios Roemmers - Merck & Co - Novartis - Pfizer - Roche - Sanofi-Aventis For more information visit http://www.researchandmarkets.com/reports/c60224 |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion